STOCK TITAN

Spero Therapeuti - SPRO STOCK NEWS

Welcome to our dedicated page for Spero Therapeuti news (Ticker: SPRO), a resource for investors and traders seeking the latest updates and insights on Spero Therapeuti stock.

Spero Therapeutics, Inc. (SPRO) is a clinical-stage biopharmaceutical company pioneering novel therapies for multidrug-resistant bacterial infections and rare diseases. This page serves as the definitive source for verified news and official updates on SPRO's research advancements, regulatory milestones, and strategic initiatives.

Investors and healthcare professionals will find timely updates on key programs including tebipenem HBr (oral carbapenem antibiotic), SPR206 (IV polymyxin), and other pipeline developments. The curated news collection covers clinical trial results, FDA communications, partnership announcements, and financial disclosures.

All content is rigorously verified to ensure accuracy and relevance for stakeholders monitoring antibiotic innovation. Bookmark this page for direct access to SPRO's latest developments in addressing critical unmet medical needs through advanced therapeutic candidates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.56%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.56%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.65%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.5%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.45%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.79%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
none

FAQ

What is the current stock price of Spero Therapeuti (SPRO)?

The current stock price of Spero Therapeuti (SPRO) is $0.71 as of April 28, 2025.

What is the market cap of Spero Therapeuti (SPRO)?

The market cap of Spero Therapeuti (SPRO) is approximately 40.5M.
Spero Therapeuti

Nasdaq:SPRO

SPRO Rankings

SPRO Stock Data

40.53M
41.52M
24.47%
24.89%
0.78%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE